Trade Fulgent Genetics, Inc. - FLGT CFD

Trading Conditions

• TypeThis financial market is available for CFD trading.Learn more about:CFDs: CFD
• Spread: 0.13
• Long position overnight funding adjustmentLong position overnight funding adjustmentMargin. Your investment$1,000.00Overnight funding adjustmentCharges from full value of position-0.021596 %(-$4.32)Trade size with leverage ~ $20,000.00Money from leverage ~ $$19,000.00Go to platform: -0.02160%
• Short position overnight funding adjustmentShort position overnight funding adjustmentMargin. Your investment$1,000.00Overnight funding adjustmentCharges from full value of position-0.000626 %(-$0.13)Trade size with leverage ~ $20,000.00Money from leverage ~ $$19,000.00Go to platform: -0.00063%
• Overnight funding adjustment time: 21:00 (UTC)
• Currency: USD
• Min traded quantity: 1
• Margin: 5.00%
• Stock exchange: United States of America
• Commission on trade: 0%
• Guaranteed stop premiumA guaranteed stop-loss (GSL) fee is only charged if the GSL is triggered. Please consult the Charges and Fees section of our website for more details.: 1%

• Margin. Your investment: $1,000.00
• Overnight funding adjustmentCharges from full value of position: -0.021596 %
  (-$4.32)

• Margin. Your investment: $1,000.00
• Overnight funding adjustmentCharges from full value of position: -0.000626 %
  (-$0.13)

Key Stats

• Prev. Close: 19.56
• Open: 19.24
• 1-Year Change: -12.27%
• Day's Range: 19.24 - 19.75

Trade Fulgent Genetics, Inc. - FLGT

Fulgent Genetics (FLGT) is a global molecular diagnostic and genetic testing services provider. 

Headquartered in Temple City, California, Fulgent Genetics was founded in 2011 as Fulgent Diagnostics. The company merges the fields of genetics, molecular biology and computer science to conduct diagnostic testing and genomic sequencing.It offers flexible testing options for physicians and patients. 

Fulgent Genetics’ portfolio consists of more than 18,000 single genes for genetic testing, 800 rare disease tests, complete genome sequencing, complete genome Copy Number Variation (CNVs) analysis, mitochondrial sequencing and CLIA/CAP quality sequencing services.

The company has received accreditations from the Clinical Laboratory Improvement Amendments (CLIA), the College of American Pathologists (CAP), the California Clinical Laboratory, the Pennsylvania Clinical Laboratory, the Maryland Medical Laboratory, the New York State Clinical Laboratory and the Rhode Island Laboratory. Its strategic partnership with Helio Health aims to help the company commercialise tests for blood-based early cancer detection. 

Fulgent Genetics Inc. stock began trading on the NASDAQ in 2016 under the ticker symbol FLGT. 

You can track the FLGT share value and price history live at http:/en-ke/en-kecapital.com.